(Q77539774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

H Bischoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R Angerbauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Boberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Petzinna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Schmidt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W Steinke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

G Thomas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

139 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

S7-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

A receptor-mediated pathway for cholesterol homeostasis

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Pharmacology of competitive inhibitors of HMG-CoA reductase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900188-9

10.1016/S0021-9150(98)00188-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9811153%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference